However, while there is an increasing trend of multidrug resistance in both Gram-negative and Gram-positive bacteria, there has been a significant global decline of investment into new drug development ( Livermore, 2012 ; Woolhouse and Farrar, 2014 ).
← all excerpts
<i>In vitro</i> Activity of Robenidine Analog NCL195 in Combination With Outer Membrane Permeabilizers Against Gram-Negative Bacterial Pathogens and Impact on Systemic Gram-Positive Bacterial Infection in Mice.
1
—
—